Cargando…
Respiratory virus-induced heterologous immunity: Part of the problem or part of the solution?
PURPOSE: To provide current knowledge on respiratory virus-induced heterologous immunity (HI) with a focus on humoral and cellular cross-reactivity. Adaptive heterologous immune responses have broad implications on infection, autoimmunity, allergy and transplant immunology. A better understanding of...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Medizin
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7100437/ https://www.ncbi.nlm.nih.gov/pubmed/32226720 http://dx.doi.org/10.1007/s40629-018-0056-0 |
_version_ | 1783511440960782336 |
---|---|
author | Pusch, Emanuel Renz, Harald Skevaki, Chrysanthi |
author_facet | Pusch, Emanuel Renz, Harald Skevaki, Chrysanthi |
author_sort | Pusch, Emanuel |
collection | PubMed |
description | PURPOSE: To provide current knowledge on respiratory virus-induced heterologous immunity (HI) with a focus on humoral and cellular cross-reactivity. Adaptive heterologous immune responses have broad implications on infection, autoimmunity, allergy and transplant immunology. A better understanding of the mechanisms involved might ultimately open up possibilities for disease prevention, for example by vaccination. METHODS: A structured literature search was performed using Medline and PubMed to provide an overview of the current knowledge on respiratory-virus induced adaptive HI. RESULTS: In HI the immune response towards one antigen results in an alteration of the immune response towards a second antigen. We provide an overview of respiratory virus-induced HI, including viruses such as respiratory syncytial virus (RSV), rhinovirus (RV), coronavirus (CoV) and influenza virus (IV). We discuss T cell receptor (TCR) and humoral cross-reactivity as mechanisms of HI involving those respiratory viruses. Topics covered include HI between respiratory viruses as well as between respiratory viruses and other pathogens. Newly developed vaccines which have the potential to provide protection against multiple virus strains are also discussed. Furthermore, respiratory viruses have been implicated in the development of autoimmune diseases, such as narcolepsy, Guillain–Barré syndrome, type 1 diabetes or myocarditis. Finally, we discuss the role of respiratory viruses in asthma and the hygiene hypothesis, and review our recent findings on HI between IV and allergens, which leads to protection from experimental asthma. CONCLUSION: Respiratory-virus induced HI may have protective but also detrimental effects on the host. Respiratory viral infections contribute to asthma or autoimmune disease development, but on the other hand, a lack of microbial encounter is associated with an increasing number of allergic as well as autoimmune diseases. Future research might help identify the elements which determine a protective or detrimental outcome in HI-based mechanisms. |
format | Online Article Text |
id | pubmed-7100437 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Springer Medizin |
record_format | MEDLINE/PubMed |
spelling | pubmed-71004372020-03-27 Respiratory virus-induced heterologous immunity: Part of the problem or part of the solution? Pusch, Emanuel Renz, Harald Skevaki, Chrysanthi Allergo J Int Review PURPOSE: To provide current knowledge on respiratory virus-induced heterologous immunity (HI) with a focus on humoral and cellular cross-reactivity. Adaptive heterologous immune responses have broad implications on infection, autoimmunity, allergy and transplant immunology. A better understanding of the mechanisms involved might ultimately open up possibilities for disease prevention, for example by vaccination. METHODS: A structured literature search was performed using Medline and PubMed to provide an overview of the current knowledge on respiratory-virus induced adaptive HI. RESULTS: In HI the immune response towards one antigen results in an alteration of the immune response towards a second antigen. We provide an overview of respiratory virus-induced HI, including viruses such as respiratory syncytial virus (RSV), rhinovirus (RV), coronavirus (CoV) and influenza virus (IV). We discuss T cell receptor (TCR) and humoral cross-reactivity as mechanisms of HI involving those respiratory viruses. Topics covered include HI between respiratory viruses as well as between respiratory viruses and other pathogens. Newly developed vaccines which have the potential to provide protection against multiple virus strains are also discussed. Furthermore, respiratory viruses have been implicated in the development of autoimmune diseases, such as narcolepsy, Guillain–Barré syndrome, type 1 diabetes or myocarditis. Finally, we discuss the role of respiratory viruses in asthma and the hygiene hypothesis, and review our recent findings on HI between IV and allergens, which leads to protection from experimental asthma. CONCLUSION: Respiratory-virus induced HI may have protective but also detrimental effects on the host. Respiratory viral infections contribute to asthma or autoimmune disease development, but on the other hand, a lack of microbial encounter is associated with an increasing number of allergic as well as autoimmune diseases. Future research might help identify the elements which determine a protective or detrimental outcome in HI-based mechanisms. Springer Medizin 2018-03-26 2018 /pmc/articles/PMC7100437/ /pubmed/32226720 http://dx.doi.org/10.1007/s40629-018-0056-0 Text en © Springer Medizin Verlag GmbH, a part of Springer Nature 2018 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Review Pusch, Emanuel Renz, Harald Skevaki, Chrysanthi Respiratory virus-induced heterologous immunity: Part of the problem or part of the solution? |
title | Respiratory virus-induced heterologous immunity: Part of the problem or part of the solution? |
title_full | Respiratory virus-induced heterologous immunity: Part of the problem or part of the solution? |
title_fullStr | Respiratory virus-induced heterologous immunity: Part of the problem or part of the solution? |
title_full_unstemmed | Respiratory virus-induced heterologous immunity: Part of the problem or part of the solution? |
title_short | Respiratory virus-induced heterologous immunity: Part of the problem or part of the solution? |
title_sort | respiratory virus-induced heterologous immunity: part of the problem or part of the solution? |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7100437/ https://www.ncbi.nlm.nih.gov/pubmed/32226720 http://dx.doi.org/10.1007/s40629-018-0056-0 |
work_keys_str_mv | AT puschemanuel respiratoryvirusinducedheterologousimmunitypartoftheproblemorpartofthesolution AT renzharald respiratoryvirusinducedheterologousimmunitypartoftheproblemorpartofthesolution AT skevakichrysanthi respiratoryvirusinducedheterologousimmunitypartoftheproblemorpartofthesolution |